Nu-Med Plus (NUMD) Financial Statements
Nu-Med Plus Financial Overview
Nu-Med Plus's market cap is currently $601.55K. The company's EPS TTM is $-0.00; its P/E ratio is -24.00; Nu-Med Plus has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ -12.90K | $ -12.97K | $ -23.04K |
| Operating Income | $ -48.95K | $ -63.33K | $ -120.53K | $ -182.17K | $ -839.00K |
| EBITDA | $ -48.95K | $ 0.00 | $ -118.26K | $ -171.68K | $ -818.00K |
| Net Income | $ -56.18K | $ -68.34K | $ -125.53K | $ -130.17K | $ -830.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 661.00 | $ 2.37K | $ 6.81K | $ 73.19K | $ 11.68K |
| Total Assets | $ 7.91K | $ 9.37K | $ 13.46K | $ 79.55K | $ 22.16K |
| Total Debt | $ 112.50K | $ 100.00K | $ 100.00K | $ 100.00K | $ 8.22K |
| Net Debt | $ 111.84K | $ 97.63K | $ 93.19K | $ 26.80K | $ -3.45K |
| Total Liabilities | $ 279.19K | $ 224.47K | $ 160.21K | $ 142.57K | $ 154.52K |
| Stockholders' Equity | $ -271.28K | $ -215.10K | $ -146.75K | $ -63.02K | $ -132.36K |
| Cash Flow | |||||
| Free Cash Flow | $ -47.98K | $ -4.43K | $ -66.39K | $ -38.48K | $ -206.83K |
| Operating Cash Flow | $ -47.98K | $ -4.43K | $ -66.39K | $ -38.48K | $ -206.83K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 46.27K | $ 0.00 | $ 0.00 | $ 100.00K | $ 30.00K |
Currency in USD